Clinical Trial Update: A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial updating the study of guselkumab in participants with fistulizing perianal Crohn's disease; status is active not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Fistulizing Crohn Disease
• Perianal Crohn Disease

Drugs mentioned

• Guselkumab (guselkumab)

Snippet

Sponsor: Janssen-Cilag Ltd. | Conditions: Fistulizing Crohns Disease, Perianal Crohns Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING